
Nutriband Responds to Fentanyl Executive Order, Highlights Development of Abuse-Deterrent Patch
Nutriband Inc. clarifies that FDA-approved prescription fentanyl therapies remain medically necessary while highlighting its development of AVERSA™ FENTANYL, an abuse-deterrent transdermal patch that addresses safety concerns and has significant market potential.
Read full story
























